Login or Register to make a submission.

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.
  • The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor).
  • The submission file is in OpenOffice, Microsoft Word, or RTF document file format.
  • Where available, URLs for the references have been provided.
  • The text is single-spaced; uses a 12-point font; employs italics, rather than underlining (except with URL addresses); and all illustrations, figures, and tables are placed within the text at the appropriate points, rather than at the end.
  • The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines.

Author Guidelines

The EMC Journal welcomes the submission of manuscripts that meet the general criteria of significance and scientific excellence. The Editorial Board of the EMC Journal agrees to accept manuscripts prepared in accordance with the “Uniform Requirements submitted to the Biomedical Journals” published in the New England Journal of Medicine in 1991 (N Engl J Med. 1991; 324: 424-8).

Editorial Scope:
* Submitted manuscripts should not be previously published or being considered for publication elsewhere.
* All submitted articles undergo double blind peer review as per recommendations by subject specific experts selected by editors.
* Reviewed manuscripts will be sent to the corresponding author for appropriate response if it is indicated.
* Acceptance is based on significance, originality, clarity and fulfillment of the criteria of the publication policy of EMC Journal.
* All the final decisions regarding the acceptance of the submitted manuscript is taken by the Editor-in-Chief of EMC Journal.
* Selection of the reviewed & accepted manuscripts intended for publication in a particular issue is decided by the Editorial Board.
* Rejected manuscript is returned if accompanied by stamped or self-addressed envelope.
* Upon acceptance for publication the copyright of the manuscript automatically transfers to the authority of EMC Journal & will not be published elsewhere either in part or whole without written permission of the copyright holder.
* The review article should be written by a subject expert.

Ethical Aspects:
* Ethical aspect of the study is very carefully considered at the time of assessment of the manuscript.
* Any manuscript that includes table, illustration or photography that have been published earlier should accompany a letter of permission for republication from the author(s) of the publication and editor/ publisher of the journal where it was published earlier.
* Permission of the patients and/ or their families to reproduce photographs of the patients where identity is not disguised should be sent with the manuscript. Otherwise the identity of study subject will be blackened out.

Article Types:
Five types of manuscripts may be submitted:
1) Editorials: It should be preferably written by invited Persons only and usually covers a single topic of contemporary interest.
2) Original Articles: These should describe new and carefully confirmed findings. The experimental procedures should be given in sufficient detail for others to verify the work. The length of a full original manuscript should be the minimum required to describe and interpret the work clearly.
3) Short Communications: A short communication is suitable for recording the results of complete small investigations or giving details of new models or hypothesis, innovative methods, techniques, images in clinical practice, letter to editors, short reports or apparatus. The style of main sections need not conform to that of original article. Short communications are 2 to 4 printed pages (about 6 to 12 manuscript pages) in length.
4) Reviews: Submissions of reviews & perspectives covering topics of current interest are welcome & encouraged. Review articles should be concise & no longer than 4 to 6 printed pages (about 12 to 18 manuscript pages). It should be focused & must be up to date. Reviews are also peer-reviewed.
5) Case Reports: This should cover uncommon and/ or interesting cases with appropriate confirmation process.

Review Process:
All manuscripts are initially screened by editor & sent to selective reviewer. Decisions will be made as rapidly as possible and EMC Journal strives to return peer-reviewer’s comments to authors within 3 weeks. The EMC Journal Editorial Board will re-review manuscripts that are accepted pending revision. The Editorial Board will try to publish the manuscript as early as possible fulfilling all the rigorous standard that Journal needs (Coding and decoding process is maintained).

Manuscript Submission:
The authors are requested to strictly follow the guide lines below for submission of manuscript to EMCJ for publication. The following documents with manuscripts are to be submitted for publication:
* A covering letter addressed to the Editor-in-Chief of the Journal.
* A Title page.
* Abstract & keywords in the first page followed by the text, prepared in the form of IMRAD.
* Authors must submit two hard copies of all documents & one copy in electronic form preferably written in a CD with adequate labeling.
* In special case, submission through E-mail with file attachment of all documents is welcome.

Covering Letter:
* All authors must sign after seeing the manuscript with the statement that they are the only authors.
* The corresponding author should mention the contribution of each author to the work.
* It should contain a declaration that this manuscript has not been submitted elsewhere or not under consideration in any Journal.
* It should clearly indicate the publication type (Original article/ Review article/ Case report/ Letter to the Editor, etc.)
* It also should mention the expected benefit of Medical Science from publishing of this article.

Authors are requested to submit manuscript & correspondence to:
Prof. Dr. Md. Zakirul Islam
Executive Editor, EMC Journal
Professor and Head, Department of Pharmacology & Therapeutics
Eastern Medical College, Kabila, Cumilla, Bangladesh
Mobile: +8801818317715

Manuscript Organization:
* Double spaced throughout with justified & 2.5 cm margins.
* Font type is Times New Roman with size 12.
* Printed on a good quality A4 80 gm paper and on one side of the paper.
* Manuscript should have uniform style, correct journal format, carefully proof read for grammar, spelling & punctuation.

Manuscript format:
In general, original article should be divided into following sections: Title page, Abstract, Body text, Tables with titles and foot notes, Graph with title, Illustrations with legends, Acknowledgement and References. Each section should be started on a separate page. Pages should be numbered consecutively beginning from the abstract.

Title page:
* Title of the article.
* Names of all the authors with their designation & institutional affiliations.
* Name of the department & institute where the study was undertaken.
* Name of the corresponding author with contact address, telephone/ mobile number and Email address.
* Disclosure of conflict of interest if any.
* Number of Tables given.
* Number of Figures given.
* Word count of Abstract and Body text.

* Summary in a single paragraph or structured with headings.
* Authors name should not be given.
* Preferably within about 250 words.
* Avoid abbreviations in the title & abstract except standard abbreviation.

Body Text:
Body text should be arranged into the following sections: Introduction, Materials and Methods, Results, Discussions, Recommendations and Limitations, Conclusion, Acknowledgement and References.

* Statement of the problem with a short discussion of its importance and significance.
* Review of the literature related to the problem with pertinent references.
* Objectives/ hypothesis/ benefits expected stated in 1-2 paragraph.

* Study type, place and period.
* Description of study variables.
* Description of study subjects and grouping.
* Selection (inclusion and exclusion) criteria of the study subjects.
* Approval of the study involving human subjects by ethical review committee and description of the ethical aspects prior to publication.
* Description of procedure, methods, apparatus, drugs or chemicals as applicable.
* Description of statistical procedure with enough detail to enable a knowledgeable reader with access to the original data to verify the reported results.

* Present result in logical sequence in text, table and illustration with most important finding first.
* Result should be described without any comment.
* Restriction of number of table and figure needed to support assessment of paper.
* Result data should not be duplicated in the table and the figure.

* Appropriate self-explanatory with brief title, not duplicate in text.
* Each table should be numbered in Romans and printed in separate pages.

* All illustrations must be numbered consecutively in Arabic numerals as they appear in the text.
* Submit print photograph of each illustration along with its electronic file.
* Figure number, title of manuscript, name of the corresponding author and arrow indicating top should be written on a sticky label affixed on the back of each.
* Scanned picture, graph, chart with title and figure number should be printed on separate page and its original data presentation file should be inserted in the CD along with text.

* Must be typed in a separate sheet of paper.
* Photomicrograph should indicate the magnification, internal scale and the method of staining.
* All drugs should be mentioned in their generic form. The commercial name may be used in parenthesis.

* Compare the positive and negative findings from the results and statistical analysis of the study with the related article and properly cite it in the reference section.
* Give emphasize on the new and important aspects of the study and the conclusions that follow from them in the context of the totality of the best available evidence.
* Avoid the repetition in detail of the data or other information given in the Introduction or the Results section of the article.
* It is useful to begin discussion for experimental studies by briefly summarizing the main findings, then explore possible mechanisms or explanations for these findings, compare and contrast the results with other relevant studies, state the limitations of the study, and explore the implications of the findings for future research and for clinical practice.

* Conclusions should be short and linked with the goals of the study but avoid unqualified statements and conclusions not adequately supported by the data.
* Particularly avoid making statements on economic benefits and costs unless the manuscript includes the appropriate economic data and analyses. Avoid claiming priority or alluding to work that has not been completed.
* State new hypotheses when warranted, but label them clearly as such.

Individuals, institution, sponsor, organization or bodies can be acknowledged in the article for their contribution or financial or any form of assistance to the work.

* For reference, use author number style (Vancouver) which is based on an ANSI standard adapted by the US National Library of Medicine (NLM).
* References should be numbered consecutively in the order in which they are first mentioned in the text.
* Identify references in the text, tables and legends by Arabic numerals in superscript.
* All citations to electronic references should be presented in numbered references following the text.
* The titles of the Journals should be abbreviated according to the style used in Index Medicus.
* Write names of six authors followed by et al. if authors number is more than six.
* It is the total responsibility of the author to provide accurate information in the reference list.

Standard Journal article:

Khalil M, Chowdhury MAI, Rahman H, Mannan S, Sultana SZ, Rahman MM, et al. Splenic Mass and its relation to age, sex and height of the individual in Bangladesh people. J Bangladesh Soc Physiol. 2008; 3(1): 71-8.
Journal article with organization as author:
American diabetes Association diabetes update. Nursing, 2003 Nov; Suppl: 19-20.
Journal article with multiple organization as author:
American Dietetic association; Dietitians of Canada. Position of Dietetic association and Dietitians of Canada: nutrition and women's health. J Am Diet Assoc 2004; 104(6): 984-1001.
Fauci AS, Lane HC. Human immunodeficiency virus disease: AIDS and related disorders. In: Kasper DL, Faici AS, Longo DL, Braunwald E, Hauser SL, Jameson JL, Editors. Harrison's principles of internal medicine, 17th ed., volume 1. USA: Mc Grow Hill Companies; 2005. pp 1076-98.
Website & Online Journal Article:
Simon J. Polycystic ovary syndrome. Available at: https://en. wiki/ Polycystic_ ovary_syndrome [Accessed on August 12, 2015]
Guidelines: WHO, South Asian regional consultation on monitoring and evaluation of maternal and neonatal health: Guidelines for investigating maternal mortality. Bangkok: World Health Organization, 2002.

Please submit your manuscript with a cover letter to the Editor-in-Chief and Executive Editor of Eastern Medical College Journal (EMCJ) by email to the following email address:;;

Authors are requested to prepare their manuscripts following the Author's Guideline of EMCJ before submission.

Authors are also requested to prepare the cover letter that should include the corresponding author's full address, email ID & contact numbers and undertaken mentioning that "manuscript has not been published so far or communicated to other journal". Ethical clearance certificate, permission letter for third party data use and other related document should be submitted with the cover letter if required.

An acknowledgement for manuscript submission will be sent to the author through email after successful reception of the manuscript and covering letter with related documents. Further communication about the acceptance and proofing of the manuscript will be done through the email.

For any kind of queries authors may write to:
or call on: +8801711747477, +8801818317715

Copyright Notice

Authors who publish in the Eastern Medical College Journal (EMCJ) agree to the following terms that:

  1. Journal retain copyright and grant the Eastern Medical College Journal (EMCJ) the right of first publication of the work.
  2. Creative Commons Licence
  3. Eastern Medical College Journal is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.


Section default policy

Privacy Statement

Bangladesh Journals Online (BanglaJOL) is a member of the Ubiquity Partner Network coordinated by Ubiquity Press. According to the EU definitions, BanglaJOL is the data controller, and Ubiquity Press are the service providers and data processors. Ubiquity Press provide the technical platform and some publishing services to BanglaJOL and operate under the principle of data minimisation where only the minimal amount of personal data that is required to carry out a task is obtained.

More information on the type of data that is required can be found in Ubiquity Press’ privacy policy below.

Ubiquity Press Privacy Policy

We take seriously our duty to process your personal data in a fair and transparent way. We collect and manage user data according to the following Privacy Policy. This document is part of our Terms of Service, and by using the press portal, affiliated journals, book, conference and repository websites (the “Websites”), you agree to the terms of this Privacy Policy and the Terms of Service. Please read the Terms of Service in their entirety, and refer to those for definitions and contacts.

What type of personal data do we handle?

There are four main categories of personal data stored by our journal platform, our press platform, and our book management system; Website User data, Author data, Reviewer data and Editor data.

The minimum personal data that are stored are:

  • full name
  • email address
  • affiliation (department, and institution)
  • country of residence

Optionally, the user can provide:

  • salutation
  • gender
  • associated URL
  • phone number
  • fax number
  • reviewing interests
  • mailing address
  • ORCiD
  • a short biography
  • interests
  • Twitter profile
  • LinkedIn profile
  • ImpactStory profile
  • profile picture

The data subjects have complete control of this data through their profile, and can request for it to be removed by contacting

What do we do to keep that data secure?

We regularly backup our databases, and we use reliable cloud service providers (Amazon, Google Cloud, Linode) to ensure they are kept securely. Backups are regularly rotated and the old data is permanently deleted. We have a clear internal data handling policy, restricting access to the data and backups to key employees only. In case of a data breach, we will report the breach to the affected users, and to the press/journal contacts within 72 hours.

How do we use the data?

Personal information is only used to deliver the services provided by the publisher. Personal data is not shared externally except for author names, affiliations, emails, and links to ORCiD and social media accounts (if provided) in published articles and books which are displayed as part of the article/book and shared externally to indexes and databases. If a journal operates under open peer review then the reviewer details are published alongside the reviewer details.

How we collect and use your data:

1. When using the website

1.1 what data we collect

  • When you browse our website, we collect anonymised data about your use of the website; for example, we collect information about which pages you view, which files you download, what browser you are using, and when you were using the site.
  • When you comment on an article or book using Disqus, we are not collecting, controlling or processing the data. More details on the DISQUS privacy policy can be found on their website.
  • When you annotate an article or book, this is done via a 3rd party plugin to the website called In using this plugin we are not collecting, controlling or processing the data. More details on the privacy policy can be found on their website.

1.2 why we collect the data

  • We use anonymised website usage data to monitor traffic, help fix bugs, and see overall patterns that inform future redesigns of the website, and provide reports on how frequently the publications on our site have been accessed from within their IP ranges.

1.3 what we do (and don’t do) with the data

  • We do not collect personal information that can be used to identify you when you browse the website.
  • We currently use Google Analytics for publication reports, and to improve the website and services through traffic analysis, but no personal identifying data is shared with Google (for example your computer’s IP is anonymised before transmission).

1.4 what to do if you want to get a copy of your data, or want your data to be removed

  • Please contact to request a copy of your data, or for your data to be removed/anonymised.

2. When registering as an author, and submitting an article or book

2.1 what data we collect

  • When registering an account we ask you to log in and provide certain personal information (such as your name and email address), and there is the option to register using an ORCiD which will pre-fill the registration form.
  • As part of submitting an article for publication, you will need to provide personally identifying information which will be used for the peer review process, and will be published. This can include ‘Affiliation’, ‘Competing interests’, ‘Acknowledgements’.

2.2 why we collect the data

  • Registering an account allows you to log in, manage your profile, and participate as an author/reviewer/editor. We use cookies and session information to streamline your use of the website (for example in order for you to remain logged-in when you return to a journal). You can block or delete cookies and still be able to use the websites, although if you do you will then need to enter your username and password to login. In order to take advantage of certain features of the websites, you may also choose to provide us with other personal information, such as your ORCiD, but your decision to utilize these features and provide such data will always be voluntary.
  • Personal data submitted with the article or book is collected to allow follow good publication ethics during the review process, and will form part of the official published record in order for the provenance of the work to be established, and for the work to be correctly attributed.

2.3 what we do (and don’t do) with the data

  • We do not share your personal information with third parties, other than as part of providing the publishing service.
  • As a registered author in the system you may be contacted by the journal editor to submit another article.
  • Any books published on the platform are freely available to download from the publisher website in PDF, EPUB and MOBI formats on the publisher’s site.
  • Any personal data accompanying an article or a book (that will have been added by the submitting author) is published alongside it. The published data includes the names, affiliations and email addresses of all authors.
  • Any articles published on the platform are freely available to download from the publisher website in various formats (e.g. PDF, XML).
  • Ubiquity Press books and articles are typeset by SiliconChips and Diacritech.This process involves them receiving the book and book associated metadata and contacting the authors to finalise the layout. Ubiquity Press work with these suppliers to ensure that personal data is only used for the purposes of typesetting and proofing.
  • For physical purchases of books on the platform Ubiquity Press use print on demand services via Lightning Source who are responsible for printing and distribution via retailers. (For example; Amazon, Book Repository, Waterstones). Lightning Source’s privacy policy and details on data handling can be found on their website.

2.4 why we store the data

  • We store the account data so that you may choose to become a reviewer and be able to perform those tasks, or to become an author and submit an article and then track progress of that article.
  • Published personal data that accompanies an article or a book forms part of the official published record in order for the provenance of the work to be established, and for the work to be correctly attributed.

2.5 what to do if you want to get a copy of your data, or want your data to be removed

  • You are able to view, change and remove your data associated with your profile. Should you choose to completely delete your account, please contact us at and we will follow up with your request as soon as possible.
  • To conform to publication ethics and best practice any personal data that is published alongside an article or book cannot be removed. If you have a query about a publication to which you are attributed please contact

3. When registering as a reviewer

3.1 what data we collect

  • To become a reviewer you must first register as a user on the website, and set your preference that you would like to be considered as a reviewer. No new personal data is collected when a registered user elects to become a reviewer.
  • When registering an account we ask you to log in and provide certain personal information (such as your name and email address), and there is the option to register using an ORCiD which will pre-fill the registration form.
  • Reviewers can also be registered by editors who invite them to review a specific article. This requires the editor to provide the reviewer’s First Name, Last Name, and Email address. Normally this will be done as part of the process of inviting you to review the article or book.
  • On submitting a review, the reviewer includes a competing interest statement, they may answer questions about the quality of the article, and they will submit their recommendation.

3.2 why we collect the data

  • The data entered is used to invite the reviewer to peer review the article or book, and to contact the reviewer during and the review process.
  • If you submit a review then the details of your review, including your recommendation, your responses to any review form, your free-form responses, your competing interests statement, and any cover letter are recorded.

3.3 what we do (and don’t do) with the data

  • This data is not shared publicly and is only accessible by the Editor and system administrators of that journal or press.
  • The data will only be used in connection with that journal or press.
  • Data that is retained post final decision is kept to conform to publication ethics and best practice, to provide evidence of peer review, and to resolve any disputes relating to the peer review of the article or book.
  • For journals or presses that publish the peer reviews, you will be asked to give consent to your review being published, and a subset of the data you have submitted will become part of the published record.

3.4 what to do if you want to get a copy of your data, or want your data to be removed

  • If you would no longer like to be registered as a reviewer you can edit your profile and tick the box ‘stop being a reviewer’. This will remove you from the reviewer database, however any existing reviews you may have carried out will remain.
  • If you have been contacted by an editor to peer review an article this means that you have been registered in the system. If you would not like to be contacted for peer review you can reply to the email requesting that your data be deleted.

4. When being registered as a co-author

4.1 what data we collect

  • Co-author data is entered by the submitting author. The submitting author will already have a user account. According to standard publishing practice, the submitting author is responsible for obtaining the consent of their co-authors to be included (including having their personal data included) in the article/book being submitted to the journal/press.
  • The requested personal data for co-authors are at the bare minimum; first name, last name, institution, country, email address. This can also include; ORCID ID, Title, Middle Name, Biographical Statement, Department, Twitter Handle, Linkedin Profile Name or ImpactStory ID.

4.2 why we collect the data

  • Assuming that it is accepted for publication, this data forms part of the official published record in order for the provenance of the work to be established, and for the work to be correctly attributed.
  • Author names, affiliations and emails are required for publication and will become part of the permanent cited record.

4.3 what we do (and don’t do) with the data

  • The co-author’s personal data is stored in the author database. This personal data is only used in relation to the publication of the associated article.
  • Any co-author data collected is added to the author database and is only used in association with the article the user is co-author on.

4.5 what to do if you want to get a copy of your data, or want your data to be removed

  • To receive a copy of your data, please contact
  • To conform to publication ethics and best practice any personal data that is published alongside an article or book cannot be removed. If you have a query about a publication to which you are attributed please contact

5. When signing-up to receive newsletters

5.1 what data we collect

  • We require you to include your name and email address

5.2 why we collect and store the data, and for how long

  • This data would be collected to keep you updated with any news about the platform or specific journal

5.3 what we do (and don’t do) with the data

  • We use mailchimp to provide our mailing list services. Their privacy policy can be found here

5.4 what to do if you want to get a copy of your data or want your data to be removed

  • All emails sent via our newsletter client will include a link that will allow you to unsubscribe from the mailing list

Notification about change of ownership or of control of data

We may choose to buy or sell assets. In the case that control of data changes to or from Ubiquity Press and a third party, or in the case of change of ownership of Ubiquity Press or of part of the business where the control of personal data is transferred, we will do our best to inform all affected users and present the options.

(Updated: 25 February 2020)